Prostate Cancer
The Prostate Cancer Test That Saved My Life
Ben Stiller announced that two years ago, he fought prostate cancer. His article here on Medium shows a unique perspective into the present controversy surrounding PSA testing. Drs.
HIFU - Novelty or innovation (Dr. Jim Hu)
Dr. Jim C. Hu speaks on the promising technology and controversy surrounding HIFU treatment for prostate cancer.
Dr. Jim C. Hu in the Washington Post - Almost all men with early prostate cancer survive 10 years, regardless of treatment
Dr. Hu speaks to the Washington Post regarding a new study that looks at 15 year mortality rates for prostate cancer patients. We look closer at the role of PSA testing in aging men and how to appropriately manage diagnosis early stage prostate cancer.
Jim C. Hu, M.D. - Expert Urges Revisiting PSA Screening After Pivotal Trial Update
The PSA screening conversation continues with the latest update from OncLive, featuring Dr. Jim C. Hu.
Dr. Jim Hu on Reevaluating PSA and the PLCO Trial OncLiveTV
Should We Abandon PSA Testing Or Make it More Targeted?
This article from Cancer Therapy Advisor features Dr. Jim Hu and resident Dr. Jonathan Shoag, continuing coverage of the PSA screening conversation.
Timothy McClure
Dr. Timothy McClure joined Brady Urology as a full time faculty member during the summer of 2016, providing his expertise to both the Departments of Urology & Radiology. Dr. McClure is an expert in imaging, image-guided therapy, and the minimally invasive treatment of urologic disease. Dr. McClure brings a unique training background to the department as he is not only a urologist, but also a board-certified radiologist who is fellowship trained in vascular and interventional radiology. Dr.
Cancer Research Foundation Awards Prestigious Clinical Investigator Award to Two Weill Cornell Medicine Scientists
Two Weill Cornell Medicine scientists have received the Damon Runyon Cancer Research Clinical Investigator Award for 2016 for their innovative research: Dr. Christopher Barbieri and Dr. Heather Yeo.
Read the full article here.
Dr. Barbieri on SPOP Mutations in Prostate Cancer (OncLive)
Christopher E. Barbieri, MD, PhD, surgeon, researcher in prostate cancer genomics, Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine, New-York Presbyterian, discusses the implications of SPOP mutations in patients with prostate cancer.
